PRICE T ROWE ASSOCIATES INC 13D and 13G filings for Tenaya Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2024-11-14 1:22 pm Sale |
2024-09-30 | 13G | Tenaya Therapeutics, Inc. TNYA |
PRICE T ROWE ASSOCIATES INC | 3,028,435 3.800% |
-1,516,108![]() (-33.36%) |
Filing |
2024-02-14 10:03 am Purchase |
2023-12-31 | 13G | Tenaya Therapeutics, Inc. TNYA |
PRICE T ROWE ASSOCIATES INC | 4,544,543 6.700% |
72,341![]() (+1.62%) |
Filing |
2023-02-14 12:38 pm Purchase |
2022-12-31 | 13G | Tenaya Therapeutics, Inc. TNYA |
PRICE T ROWE ASSOCIATES INC | 4,472,202 6.700% |
1,478,699![]() (+49.40%) |
Filing |
2022-02-14 2:34 pm Purchase |
2021-12-31 | 13G | Tenaya Therapeutics, Inc. TNYA |
PRICE T ROWE ASSOCIATES INC | 2,993,503 7.200% |
2,993,503![]() (New Position) |
Filing |